# Biotechnology
Latest news and articles about Biotechnology
Total: 22 articles found
Nona Biosciences Bolsters Global R&D Edge with Appointment of Shouhua Xiao as Chief Scientific Officer
Nona Biosciences has appointed Dr. Shouhua Xiao as CSO to drive its scientific strategy and enhance its 'Idea to IND' antibody discovery services. The move underscores the company's global ambitions and its focus on translating proprietary platform technologies into clinical successes.
Labor Standoff at Samsung Biologics Eases as Union Ends Historic First Strike
Samsung Biologics union members have agreed to end their three-day walkout—the first in the company's history—and return to the negotiating table. The talks, mediated by government labor officials, aim to resolve a dispute over compensation that highlights growing labor assertiveness within the Samsung Group.
The Milk of Longevity: Yili’s Strategic Bet on China’s ‘Silver Economy’
Yili Group’s sweep of innovation awards at the FFC 2026 Functional Food Conference underscores its strategic pivot toward China’s burgeoning silver economy. By blending traditional Chinese wellness concepts with advanced dairy science, the company is positioning itself to capture the high-growth adult nutrition segment amidst a national demographic shift.
Turning Back the Biological Clock: Cellular Reprogramming Braces for Human Trials
Partial cellular reprogramming, a biotechnology aimed at reversing the aging process by resetting cellular markers, is set to begin its first human clinical trials this year following promising results in animal models.
Stem Cell Breakthrough: Solving the Stability Puzzle in Type 1 Diabetes Treatment
Researchers at the Karolinska Institute have developed a technology to stabilize the production of insulin-secreting cells from human stem cells. This breakthrough addresses a major technical bottleneck in regenerative medicine, paving the way for more reliable and scalable stem cell treatments for Type 1 diabetes.
A Breath of Prevention: Graphene Sensors Promise Rapid Screenings for Chronic Illness
Russian researchers have developed a graphene-polymer sensor capable of detecting chronic diseases like diabetes and heart failure through breath analysis. This non-invasive technology offers a rapid, highly sensitive alternative to traditional diagnostic methods, potentially revolutionizing early-stage medical screening.
Regulatory Renaissance: How New Policy Orders are Unlocking China’s Stem Cell Ambitions
China is implementing a landmark regulatory overhaul to streamline the transition of stem cell research from hospital labs to clinical practice. Centered in Shanghai's Zhangjiang hub, this new policy framework aims to leverage real-world clinical data to establish global leadership in regenerative medicine while enforcing strict ethical and safety standards.
OpenAI Steps into the Lab: GPT-Rosalind and the High-Stakes Battle for AI-Driven Cures
OpenAI has launched GPT-Rosalind, a specialized AI model for drug discovery, marking a direct challenge to Google's dominance in the life sciences sector. Partnering with industry leaders like Moderna and Amgen, OpenAI aims to leverage its generative technology to accelerate the translation of biological data into clinical medical applications.
The Great Leap for Regenerative Medicine: Japan’s Regulatory Gamble Sparks a Global iPSC Race
The global iPSC therapy market has entered a critical clinical phase following Japan's landmark 2026 conditional approvals for heart failure and Parkinson's treatments. While breakthroughs in China and the US demonstrate the curative potential for chronic diseases, the industry must now solve the dual challenges of high manufacturing costs and regulatory safety monitoring.
The Pig Paradigm: How Ultrasound 3D Printing is Breaking the Brain-Computer Barrier
Researchers in Shenzhen have pioneered a technique using ultrasound to 3D print electrodes inside a pig's scalp, allowing for high-fidelity brainwave capture without invasive surgery. This approach leverages the cost-effectiveness and biological similarities of pigs to humans, potentially disrupting the billion-dollar EEG market.
Neural Rewiring: Shanghai Biotech Secures Global First with Dual US-China Approval for Epilepsy Cell Therapy
Shanghai's Yuesai Biotechnology has become the first company globally to receive IND approval from both the US FDA and China's CDE for an iPSC-derived cell therapy targeting refractory epilepsy, marking a major breakthrough in regenerative medicine.
Shenzhen’s Bio-Blueprint: The ‘Cell Ten Articles’ and China’s Quest for Genomic Leadership
Shenzhen has launched a comprehensive policy package known as the 'Cell Ten Articles' to accelerate the growth of its cell and gene therapy industries. The initiative is a key part of China's strategic shift toward high-end biotechnology as a pillar for future economic growth and national security.